Journal of Psychopharmacology : Impact Factor & More
eISSN: 1461-7285pISSN: 0269-8811
Share this on:
Key Metrics
CiteScore 
6.8
Impact Factor
< 5
SNIP
1.23
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal of Psychopharmacology
Journal of Psychopharmacology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Psychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Psychopharmacology
Angiotensin II and angiotensin-(1-7) neurotransmissions in the medial amygdala differently control cardiovascular and anxiogenic-like responses to stress in rats.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.
- 24 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Enhanced cognitive protection through the combination of Amylovis-201, an anti-amyloidogenic agent with sigma-1 receptor agonist activity, and environmental enrichment in mice.
- 24 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Angiotensin II and angiotensin-(1-7) neurotransmissions in the medial amygdala differently control cardiovascular and anxiogenic-like responses to stress in rats.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis.
- 25 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.
- 24 Jun 2026
- Journal of psychopharmacology (Oxford, England)
Enhanced cognitive protection through the combination of Amylovis-201, an anti-amyloidogenic agent with sigma-1 receptor agonist activity, and environmental enrichment in mice.
- 24 Jun 2026
- Journal of psychopharmacology (Oxford, England)
FAQs on Journal of Psychopharmacology
How long has Journal of Psychopharmacology been actively publishing? 
What is the publishing frequency of Journal of Psychopharmacology?
How many articles did Journal of Psychopharmacology publish last year?
What is the eISSN & pISSN for Journal of Psychopharmacology?
What is Citescore for Journal of Psychopharmacology?
What is SNIP score for Journal of Psychopharmacology?
Who is the publisher of Journal of Psychopharmacology?
